KOPRAN vs VINEETLAB: Stock Comparison

Kopran Limited vs Vineet Laboratories Limited

Live data: 29 May 2026, 4:01 PM IST • Source: NSE and company filings

Kopran Limited is the larger company by market capitalisation. Kopran Limited shows a higher dividend yield, lower leverage and a higher ROCE, while Vineet Laboratories Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kopran Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KOPRAN is more favourable on 7 of 10 scored metrics and VINEETLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KOPRAN is the larger company
₹942 Cr vs ₹73 Cr
EPS
KOPRAN has higher earnings per share
₹3.41 vs ₹-20.47
Dividend Yield
KOPRAN has a higher dividend yield
1.59% vs 0%
Revenue Growth (TTM YoY)
VINEETLAB has faster revenue growth
11.05% vs -3.66%
EPS Growth (TTM YoY)
VINEETLAB has faster EPS growth
0% vs -71.88%
Qtr Sales Growth
KOPRAN has stronger quarterly sales growth
-3.03% vs -68.8%
Qtr Profit Growth
VINEETLAB has stronger quarterly profit growth
59.2% vs -32.9%
ROCE
KOPRAN has a higher ROCE
9.75% vs -28%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKOPRANVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKOPRANVINEETLAB
Live Price₹206.27₹38.55
Day Change6.56%5.79%
Volume38.55 L2.02 L
52-Week High₹219₹49.99
52-Week Low₹107₹27.96
Distance from 52W High-5.81%-22.88%

Valuation

MetricKOPRANVINEETLAB
Market Cap₹942 Cr₹73 Cr
P/E Ratio38.28x
P/B Ratio1.86x
EPS₹3.41₹-20.47
Book Value₹107.35₹15.84
Dividend Yield1.59%0%

Growth

MetricKOPRANVINEETLAB
Revenue Growth (TTM YoY)-3.66%11.05%
EPS Growth (TTM YoY)-71.88%0%
Qtr Sales Growth-3.03%-68.8%
Qtr Profit Growth-32.9%59.2%

Profitability & Leverage

MetricKOPRANVINEETLAB
ROE4.85%
ROCE9.75%-28%
Net Margin3.78%-26.92%
Operating Margin6.58%-22.4%
Debt to Equity0.29x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKOPRANVINEETLAB
Promoter Holding44.42%5.98% 6.48 pp
FII Holding0.51% 0.06 pp0.36% 0.36 pp
DII Holding0%
Public Holding55.06% 0.06 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kopran Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.